Clinical Trial Update: Naltrexone Augmentation of Nicotine Patch Therapy - 1 [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating naltrexone augmentation of nicotine patch therapy for Tobacco Use Disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tobacco Use Disorder

Drugs mentioned

• Naltrexone (Naltrexone)
• Nicotine patch (nicotine patch)

Snippet

Sponsor: National Institute on Drug Abuse (NIDA) | Conditions: Tobacco Use Disorder | Phase 3 | Status: COMPLETED